Can JAK inhibition prevent GVHD?
In this issue of Blood, Pidala et al report on the results of a multicenter phase 2 trial, in which a
Please make a donation to the Aplastic Anemia and MDS International Foundation this holiday season.
In this issue of Blood, Pidala et al report on the results of a multicenter phase 2 trial, in which a
TITLE Azacitidine and venetoclax in previously untreated acute myeloid leukemia.
Alejandro Marinos Velarde, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in
Dr. Gloria F. Gerber is an Assistant Professor of Medicine at Johns Hopkins University in the Division of Hematology. She received her undergraduate degree in Biology with High Honors from Dartmouth College and M.D. from Rutgers Robert Wood Johnson Medical School. She completed her Internal Medicine Residency at New York Presbyterian Weill Cornell Medical Center and Fellowship in Hematology at Johns Hopkins. Dr.
Dr. Pankit Vachhani is an Assistant Professor of Medicine at the University of Alabama at Birmingham and Associate Scientist of Experimental Therapeutics. He graduated from Weill Cornell Medical College in Qatar in 2012 and on to complete his internal medicine residency at Virginia Commonwealth University, followed by a fellowship in hematology/oncology at Roswell Park Comprehensive Cancer Center in Buffalo, NY. Clinical Interests & Research: At UAB, he is involved in multiple clinical trials as a principal investigator. He leads the Leukemia/BMT working group.